Business context and reporting period
Minerals Technologies Inc. (NYSE: MTX) filed this Form 10-K for the fiscal year ended December 31, 2022. It is a global specialty minerals and technology company with three 2022 reporting segments: Performance Materials, Specialty Minerals, and Refractories. The filing reports full-year results; it does not provide a clear standalone fourth-quarter financial summary.
Performance Materials generated 53% of sales, Specialty Minerals 31%, and Refractories 16%. In the first quarter of 2023, the company expected to reorganize into Consumer & Specialties and Engineered Solutions segments.
Financial results and key metrics
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Net sales | $2,125.5 million | $1,858.3 million | +14.4% |
| Production margin | $465.0 million; 21.9% | $446.5 million; 24.0% | Margin down 2.1 percentage points |
| Income from operations | $214.8 million; 10.1% of sales | $235.7 million; 12.7% of sales | -8.9% |
| Net income attributable to MTI | $122.2 million | $164.4 million | -25.7% |
| Diluted EPS attributable to MTI | $3.73 | $4.86 | Down from prior year |
| Cash provided by operations | $105.7 million | $232.4 million | Down $126.7 million |
Consolidated net income, including non-controlling interests, was $126.3 million versus $168.5 million. The effective tax rate was 20.5%, compared with 18.1%.
Segment results: Performance Materials sales were $1,127.7 million (+15.5%) and operating income was $127.2 million, with a 11.3% margin. Specialty Minerals sales were $648.4 million (+12.0%) and operating income was $41.3 million, with a 6.4% margin. Refractories sales were $349.4 million (+15.2%) and operating income was $57.6 million, with a 16.5% margin.
Cash, liquidity and debt: Year-end cash and cash equivalents were $247.2 million, plus $5.6 million in short-term investments. The company described available liquidity as more than $400 million, including cash and revolving-credit availability. At year-end it had $115.0 million drawn and $10.5 million in letters of credit under its $300 million revolver. Aggregate principal indebtedness was reported as $1,070.1 million; balance-sheet short- and long-term debt totaled $1,062.3 million carrying value. The company refinanced its secured facilities in August 2022, extending their maturity to 2027; $400 million of 5.0% senior notes are due 2028. Capital expenditures were $82.3 million.
Material changes versus the prior year
- Sales rose across all three segments, supported by consumer pet-care demand and acquisitions, environmental-products activity, new PCC volumes, and stronger steel-market conditions. Concept Pet contributed $14.7 million of 2022 sales; Normerica contributed $70.0 million of incremental sales.
- Foreign exchange reduced 2022 sales by approximately $100 million, or 6 percentage points of growth.
- Cost of sales increased 17.6%, faster than sales. Management attributed margin pressure to inflation in energy and manufacturing costs, supply-chain and logistics challenges, and delays between cost increases and pricing actions.
- Operating income included $32.6 million of litigation costs related to talc-product claims and $5.1 million of acquisition-related costs. Net income also reflected $6.9 million of debt-extinguishment expense and a $3.5 million non-cash pension settlement charge.
- Operating cash flow fell substantially, which management attributed to a strategic inventory build, higher accounts receivable associated with pricing, and inflation in inventory and other assets. Inventories increased to $348.8 million from $297.7 million.
Outlook, risks and unusual items
Management emphasized innovation, product development, geographic expansion, pet-care growth, environmental and infrastructure products, paper-packaging opportunities, and selective acquisitions. It forecast 2023 capital expenditures of $80 million to $90 million. The filing does not provide quantified 2023 sales, earnings, or EPS guidance. Management expected steel consumption to be similar to 2022 levels and paper consumption to remain similar to prior-year levels in North America and Europe.
The company reported 440 open asbestos cases at December 31, 2022 involving alleged exposure to asbestos-containing materials related to talc products sold by its Barretts Minerals subsidiary. It accrued $31 million during 2022 for defense, settlements, and reserves; management said ultimate outcomes and potential amounts beyond accrued liabilities cannot be predicted. The company states that it considers the claims meritless and the products safe. Certain pre-IPO liabilities may be covered by Pfizer indemnification, subject to the terms of the agreements.
Other material risks include cyclical customer industries; declining printing-and-writing paper demand and the risk of satellite PCC contract non-renewal; energy, raw-material, freight and shipping cost volatility; foreign-exchange and variable-rate debt exposure; leverage and debt covenant restrictions; international, geopolitical and supply-chain disruptions; environmental and mine-permit obligations; and cybersecurity threats. The company reported that it was in compliance with its credit-facility covenants. A one-percentage-point interest-rate change was estimated to affect annual interest expense by $21 million.
KPMG issued unqualified opinions on the financial statements and internal control over financial reporting. The auditor identified measurement of projected pension benefit obligations, particularly discount-rate assumptions, as a critical audit matter.
Investor facts to verify
- Review the talc litigation docket, the $31 million accrued reserve, subsequent developments, and the scope of any Pfizer indemnification.
- Assess the sustainability of cash generation and working-capital needs, especially inventory and receivables, after the 2022 operating-cash-flow decline.
- Confirm debt balances, borrowing availability, interest-rate exposure, refinancing terms, and ongoing covenant headroom.
- Evaluate pricing recovery against inflation and logistics costs, and track margins by segment—particularly Specialty Minerals after its litigation-related charge.
- Monitor paper-mill demand, satellite PCC contract renewals, and the commercial ramp-up of new plants and growth initiatives.
- Review the 2023 segment realignment and subsequent reporting for changes in segment performance or comparability.